- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 217 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 25.06.2026 / 23:03 CET/CEST
The issuer... ► Artikel lesen | |
| 16.06. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index | 296 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Science
NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index 16.06.2026 / 14:35 CET/CEST
The issuer... ► Artikel lesen | |
| 12.06. | NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K, Current Report | 2 | SEC Filings | ||
| 12.06. | NEUROONE MEDICAL TECHNOLOGIES Corp - 10-Q/A, Quarterly Report | 2 | SEC Filings | ||
| 08.06. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) to Present at the Planet MicroCap Las Vegas 2026 Conference Wednesday, June 17, 2026 at 12:00 p.m. Pacific Time | 308 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) to Present at the Planet MicroCap Las Vegas 2026 Conference Wednesday, June 17, 2026 at 12:00 p.m.... ► Artikel lesen | |
| NEUROONE MEDICAL TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 28.05. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026 | 349 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting... ► Artikel lesen | |
| 22.05. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026 | 488 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026... ► Artikel lesen | |
| 22.05. | NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 18.05. | Trotz verfehlter Q2-Prognosen: NeuroOne-Aktie im Aufwind | 3 | Investing.com Deutsch | ||
| 12.05. | NeuroOne Medical Tech Q2 2026 Earnings Call Transcript | 1 | Benzinga.com | ||
| 12.05. | NeuroOne Medical Technologies GAAP EPS of -$0.25 misses by $0.02, revenue of $2.4M misses by $0.18M | 1 | Seeking Alpha | ||
| 12.05. | NeuroOne outlines ISO 13485 certification in latter part of 2026 while targeting drug delivery availability in second half of fiscal 2026 | 2 | Seeking Alpha | ||
| 12.05. | NeuroOne verfehlt Q2-Prognosen: Aktie gibt nach | 1 | Investing.com Deutsch | ||
| 12.05. | EQS-News: NeuroOne Medical Technologies: NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update | 1.247 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update 12.05.2026 / 14:03 CET/CEST
The... ► Artikel lesen | |
| 12.05. | NEUROONE MEDICAL TECHNOLOGIES Corp - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 12.05. | NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 04.05. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Regains Compliance With Nasdaq Listing Requirement | 288 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Regains Compliance With Nasdaq Listing Requirement 04.05.2026 / 14:34 CET/CEST
The issuer is solely... ► Artikel lesen | |
| 30.04. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Announces Chief Financial Officer Succession Plan | 461 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Announces Chief Financial Officer Succession Plan 30.04.2026 / 14:32 CET/CEST
The issuer is solely... ► Artikel lesen | |
| 30.04. | NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 28.04. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) to Report Second Quarter Fiscal Year 2026 Financial Results on Tuesday, May 12 at 8:30 a.m. Eastern Time | 334 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) to Report Second Quarter Fiscal Year 2026 Financial Results on Tuesday, May 12 at 8:30 a.m. Eastern... ► Artikel lesen |
1 2 3 Weiter >>
41 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 3,560 | 0,00 % | Plus Therapeutics wins Elevance Health coverage deal | ||
| ORGANON | 11,815 | -0,46 % | Organon and Henlius launch Prolia and Xgeva biosimilars in Canada | ||
| QUIDELORTHO | 10,820 | +1,03 % | QuidelOrtho Corporation: QuidelOrtho Appoints Micah Young as Chief Financial Officer | Seasoned medical technology finance executive brings more than two decades of leadership at global public companies SAN DIEGO, June 23, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq:... ► Artikel lesen | |
| NANO-X IMAGING | 0,885 | -43,64 % | Nano-X tumbles after Q1 revenue miss, going concern risks | ||
| ROCKWELL MEDICAL | 0,605 | +0,83 % | ROCKWELL MEDICAL, INC. - 8-K, Current Report | ||
| NUWELLIS, INC | 0,090 | +1,57 % | XFRA ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA92838G1090 Visionary Metals Corp. 25.06.2026 CA92838G2080 Visionary Metals Corp. 26.06.2026 Tausch 4:1US67113Y7022 Nuwellis... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 21,495 | +3,09 % | Evercore ISI initiates Procept BioRobotics stock with outperform rating | ||
| NEURONETICS | 1,090 | -2,24 % | Neuronetics, Inc. - 8-K, Current Report | ||
| PULSE BIOSCIENCES | 22,800 | +0,88 % | Pulse Biosciences, Inc.: Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse Cardiac Catheter System for Atrial Fibrillation | U.S. IDE Enrollment follows groundbreaking 96% procedural success at 12 months in European feasibility study Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse technology using proprietary... ► Artikel lesen | |
| PROGYNY | 27,370 | +1,79 % | Truist raises Progyny stock price target to $33 on growth outlook | ||
| OPTIMIZERX | 4,900 | 0,00 % | OptimizeRx Corporation: OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms | ||
| PAVMED | 3,950 | -0,38 % | PAVmed Inc. - 8-K, Current Report | ||
| ORTHOFIX MEDICAL | 7,900 | +1,94 % | Orthofix Medical Inc. - 8-K, Current Report | ||
| OWLET | 5,340 | 0,00 % | Owlet (OWLT) Moves 7.3% Higher: Will This Strength Last? | ||
| QTREX QUANTUM | 1,635 | -3,82 % | QTREX announces management plan to purchase up to 2M shares |
NEUROONE MEDICAL TECHNOLOGIES CORPORATION gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 3,250 Euro und damit -0,61 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEUROONE MEDICAL TECHNOLOGIES CORPORATION finden Sie auf Wallstreet Online.